Research output per year
Research output per year
Personal profile
In Korean
민상현 교수(첨단기술융합대학 혁신신약학과)
Education
o (1997) B..S, Chungbuk National University
o (1999) M.S., Chungbuk National University
o (2009) Ph.D., KAIST
o (1999) M.S., Chungbuk National University
o (2009) Ph.D., KAIST
Professional Experience
o (2024~Present) Assistant Professor, Kyungpook National University, Daegu, Korea
o (2012~2024) Principal Researcher, K-MEDI hub, Daegu, Korea
o (2009~2012) Research Fellow, Harvard Medical School (BIDMC), MA, USA
o (2006~2009) Researcher-Postdoctoral Researcher, KAIST, Daejeon, Korea
o (1999~2006) Researcher, KRIBB, Daejeon, Korea
o (2012~2024) Principal Researcher, K-MEDI hub, Daegu, Korea
o (2009~2012) Research Fellow, Harvard Medical School (BIDMC), MA, USA
o (2006~2009) Researcher-Postdoctoral Researcher, KAIST, Daejeon, Korea
o (1999~2006) Researcher, KRIBB, Daejeon, Korea
Research Interests
Focusing on synthetic drug development, we try to discover and develop small-molecule drugs based on the target-oriented drug discovery for several diseases including cancers, osteoporosis, obesity and diabetes. Also, we are interested in phenotype based drug screening using patient-originated iPS (induced pluripotent stem cells) anc cancer stem cells (CSC) as a trial of drug reposition.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Sang-Hyun Min is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Advancing Cardiovascular Drug Screening Using Human Pluripotent Stem Cell-Derived Cardiomyocytes
Oh, J., Kwon, O. B., Park, S. W., Kim, J. W., Lee, H., Kim, Y. K., Choi, E. J., Jung, H., Choi, D. K., Oh, B. J. & Min, S. H., Jul 2024, In: International Journal of Molecular Sciences. 25, 14, 7971.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Inhibitory Effect of Etravirine, a Non-Nucleoside Reverse Transcriptase Inhibitor, via Anterior Gradient Protein 2 Homolog Degradation against Ovarian Cancer Metastasis
Ly, T. T. G., Yun, J., Ha, J. S., Kim, Y. J., Jang, W. B., Van Le, T. H., Rethineswaran, V. K., Choi, J., Kim, J. H., Min, S. H., Lee, D. H., Yang, J. S., Chung, J. S. & Kwon, S. M., 1 Jan 2022, In: International Journal of Molecular Sciences. 23, 2, 944.Research output: Contribution to journal › Article › peer-review
Open Access9 Scopus citations -
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 directly binds and stabilizes Nrf2 in breast cancer
Saeidi, S., Kim, S. J., Guillen-Quispe, Y. N., Jagadeesh, A. S. V., Han, H. J., Kim, S. H., Zhong, X., Piao, J. Y., Kim, S. J., Jeong, J., Shin, Y. J., Cha, Y. J., Lee, H. B., Han, W., Min, S. H., Tian, W., Kitamura, H. & Surh, Y. J., Jan 2022, In: FASEB Journal. 36, 1, e22068.Research output: Contribution to journal › Article › peer-review
12 Scopus citations -
D-mannitol induces a brown fat-like phenotype via a β3-adrenergic receptor-dependent mechanism
Jeon, H. J., Choi, D. K., Choi, J., Lee, S., Lee, H., Yu, J. H. & Min, S. H., Apr 2021, In: Cells. 10, 4, 768.Research output: Contribution to journal › Article › peer-review
Open Access15 Scopus citations -
Genome editing of hPSCs: Recent progress in hPSC-based disease modeling for understanding disease mechanisms
Choi, D. K., Kim, Y. K., HoonYu, J., Min, S. H. & Park, S. W., Jan 2021, Reprogramming the Genome: CRISPR-Cas-based Human Disease Therapy. Singh, V. (ed.). Elsevier B.V., p. 271-287 17 p. (Progress in Molecular Biology and Translational Science; vol. 181).Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
1 Scopus citations